These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10448723)

  • 1. Influence of physicians' attitudes on reporting adverse drug events: a case-control study.
    Figueiras A; Tato F; Fontaiñas J; Gestal-Otero JJ
    Med Care; 1999 Aug; 37(8):809-14. PubMed ID: 10448723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' attitudes towards voluntary reporting of adverse drug events.
    Figueiras A; Tato F; Fontaiñas J; Takkouche B; Gestal-Otero JJ
    J Eval Clin Pract; 2001 Nov; 7(4):347-54. PubMed ID: 11737526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.
    Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
    Drug Saf; 2005; 28(9):825-33. PubMed ID: 16119975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.
    Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
    Drug Saf; 2006; 29(4):331-40. PubMed ID: 16569082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician knowledge, attitudes, and behavior related to reporting adverse drug events.
    Rogers AS; Israel E; Smith CR; Levine D; McBean AM; Valente C; Faich G
    Arch Intern Med; 1988 Jul; 148(7):1596-600. PubMed ID: 3382304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy students' attitudes toward reporting serious adverse drug events.
    Gavaza P; Bui B
    Am J Pharm Educ; 2012 Dec; 76(10):194. PubMed ID: 23275659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    Res Social Adm Pharm; 2011 Dec; 7(4):369-82. PubMed ID: 21272531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    Br J Clin Pharmacol; 2011 Jul; 72(1):143-52. PubMed ID: 21332572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population?
    Green JL; Hawley JN; Rask KJ
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):31-9. PubMed ID: 17608245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurses' attitudes and spontaneous adverse drug reaction reporting: a case-control study in Portugal.
    Mendes Marques JI; Polónia JM; Figueiras AG; Costa Santos CM; Herdeiro MT
    J Nurs Manag; 2016 Apr; 24(3):409-16. PubMed ID: 26481698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals.
    Stergiopoulos S; Brown CA; Felix T; Grampp G; Getz KA
    Drug Saf; 2016 Nov; 39(11):1117-1127. PubMed ID: 27638657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of physicians' attitudes on under-notifying infectious diseases: a longitudinal study.
    Figueiras A; Lado E; Fernández S; Hervada X
    Public Health; 2004 Oct; 118(7):521-6. PubMed ID: 15351226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Texas pharmacists' opinions on reporting serious adverse drug events to the Food and Drug Administration: a qualitative study.
    Gavaza P; Brown CM; Khoza S
    Pharm World Sci; 2010 Oct; 32(5):651-7. PubMed ID: 20652830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database.
    Sonawane KB; Cheng N; Hansen RA
    J Manag Care Spec Pharm; 2018 Jul; 24(7):682-690. PubMed ID: 29952714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.
    de Vries ST; Haaijer-Ruskamp FM; de Zeeuw D; Denig P
    Health Qual Life Outcomes; 2014 Aug; 12():103. PubMed ID: 25115618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of social influences on pharmacists' intention to report adverse drug events.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Steinhardt M; Wilson JP
    J Am Pharm Assoc (2003); 2012; 52(5):622-9. PubMed ID: 23023842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of under-reporting of adverse drug reactions: a systematic review.
    Lopez-Gonzalez E; Herdeiro MT; Figueiras A
    Drug Saf; 2009; 32(1):19-31. PubMed ID: 19132802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Texas pharmacists' knowledge of reporting serious adverse drug events to the Food and Drug Administration.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    J Am Pharm Assoc (2003); 2011; 51(3):397-403. PubMed ID: 21555292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse drug reactions and a program of voluntary notification: an opinion survey of primary care physicians].
    Serrano Cózar G; Esteban Calvo C; Gijón Porta JA; Vaquero Turiño I; Vázquez Burgos MI; Ibáñez Ruiz C; Frías Iniesta J
    Aten Primaria; 1997 Apr; 19(6):307-12. PubMed ID: 9264670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions.
    Hasford J; Goettler M; Munter KH; Müller-Oerlinghausen B
    J Clin Epidemiol; 2002 Sep; 55(9):945-50. PubMed ID: 12393084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.